Pathogenesis of Higher Blood Pressure and Worse Renal Function in Salt-Sensitive Hypertension

Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. Methods: We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in norma...

Full description

Saved in:
Bibliographic Details
Published inKidney & blood pressure research Vol. 46; no. 2; pp. 236 - 244
Main Authors Chu, Yuguang, Zhou, Yan, Lu, Shihua, Lu, Feng, Hu, Yuanhui
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.04.2021
Karger Publishers
Subjects
Online AccessGet full text
ISSN1420-4096
1423-0143
1423-0143
DOI10.1159/000515088

Cover

Loading…
Abstract Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. Methods: We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series. Results: The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group. Conclusions: Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed.
AbstractList The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series. The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group. Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed.
The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain.BACKGROUNDThe underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain.We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series.METHODSWe recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series.The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group.RESULTSThe SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group.Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed.CONCLUSIONSDifferences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed.
Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. Methods: We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series. Results: The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group. Conclusions: Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed.
Author Chu, Yuguang
Zhou, Yan
Lu, Shihua
Hu, Yuanhui
Lu, Feng
Author_xml – sequence: 1
  givenname: Yuguang
  surname: Chu
  fullname: Chu, Yuguang
– sequence: 2
  givenname: Yan
  surname: Zhou
  fullname: Zhou, Yan
– sequence: 3
  givenname: Shihua
  surname: Lu
  fullname: Lu, Shihua
– sequence: 4
  givenname: Feng
  surname: Lu
  fullname: Lu, Feng
– sequence: 5
  givenname: Yuanhui
  surname: Hu
  fullname: Hu, Yuanhui
  email: *Yuanhui Hu, huiyuhui55@sohu.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33794518$$D View this record in MEDLINE/PubMed
BookMark eNpt0ctvEzEQB2ALFdEHHLgjZIkLHJba68euj7SipKISVQvihFYT72zqsLGD7UXqf4_ThByqXvzS559GM8fkwAePhLzm7CPnypwyxhRXrG2fkSMua1ExLsXBw5lVkhl9SI5TWm4YY_ULcihEY6Ti7RH5dQ35LizQY3KJhoHO3OIOIz0bQ-jpdcSUpogUfE9_hpiQ3qCHkV5M3mYXPHWe3sKYq1v0yWX3F-nsfo0xb67BvyTPBxgTvtrtJ-THxefv57Pq6tuXy_NPV5VVguXKGGu11E0_Rw4GBTKUwBVqBC373oKyzEKLZZFD3WgJjSqoFrogo0CckMttbh9g2a2jW0G87wK47uEhxEUHMTs7YmeNkEbXXDCjpGoEWN3O22bOaw1o675kvd9mrWP4M2HK3coli-MIHsOUuro0WhnOuC703SO6DFMs_dkoKaRoSo-LertT03yF_b68_0Mo4MMW2BhSijjsCWfdZsDdfsDFnj6y1mXYjCJHcOOTP3ZF_oa4wLjP_np2sxXduh-KevOk2oX8A4tpuZg
CitedBy_id crossref_primary_10_1159_000542828
crossref_primary_10_3390_nu15071732
crossref_primary_10_1016_j_ultsonch_2022_106150
crossref_primary_10_3899_jrheum_220635
crossref_primary_10_1080_17425255_2024_2398628
crossref_primary_10_3389_fcvm_2023_1205475
Cites_doi 10.1038/s41581-019-0121-z
10.1556/650.2019.31308
10.1159/000180580
10.1158/1078-0432.CCR-07-4499
10.1016/0002-9343(78)90045-1
10.1002/0471140864.ps2701s72
10.2337/diabetes.51.7.2270
10.1161/01.cir.55.5.779
10.1016/j.ihj.2017.09.223
10.1016/S0140-6736(97)05189-1
10.1093/eurheartj/eht151
10.1097/HJH.0b013e3283375974
10.1158/1078-0432.CCR-08-0071
10.1093/nar/gkw1092
10.1007/s11906-018-0903-x
10.1161/01.hyp.17.1_suppl.i61
ContentType Journal Article
Copyright 2021 The Author(s). Published by S. Karger AG, Basel
2021 The Author(s). Published by S. Karger AG, Basel.
Copyright_xml – notice: 2021 The Author(s). Published by S. Karger AG, Basel
– notice: 2021 The Author(s). Published by S. Karger AG, Basel.
DBID M--
AAYXX
CITATION
NPM
3V.
7QL
7T7
7U9
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
S0X
7X8
DOA
DOI 10.1159/000515088
DatabaseName Karger Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Technology Research Database
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic

Technology Research Database
CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: M--
  name: Karger Open Access
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1423-0143
EndPage 244
ExternalDocumentID oai_doaj_org_article_c934962130954573ac68b87b126aec2d
33794518
10_1159_000515088
515088
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0R~
0~B
29L
30W
327
36B
3O.
3V.
4.4
5GY
5RE
5VS
7X7
88E
8AO
8FI
8FJ
8UI
AAYIC
ABOCM
ABPAZ
ABUWG
ACGFO
ACGFS
ACPRK
ADBBV
ADFRT
AENEX
AEYAO
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CS3
CYUIP
DIK
DU5
E0A
EBS
EMB
EMOBN
F5P
FB.
FYUFA
GROUPED_DOAJ
HMCUK
HZ~
IAO
IHR
IHW
KQ8
KUZGX
M--
M1P
N9A
O1H
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
RIG
RKO
RNS
S0X
SV3
UJ6
UKHRP
.GJ
34G
39C
53G
AAYXX
ABBTS
ABWCG
ACQXL
ADAGL
AFJJK
AFSIO
AHFRZ
APPQY
CAG
CITATION
COF
EJD
IPNFZ
ITC
PHGZM
PHGZT
RXVBD
ZXP
NPM
PJZUB
PPXIY
7QL
7T7
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c530t-99cc6467dbe1a9e3e0e4a15e6ea64ddca5c0ca8e0ca4f2764a753e023615e95a3
IEDL.DBID DOA
ISSN 1420-4096
1423-0143
IngestDate Wed Aug 27 01:18:02 EDT 2025
Fri Jul 11 06:44:28 EDT 2025
Fri Jul 25 21:21:27 EDT 2025
Mon Jul 21 05:38:57 EDT 2025
Thu Apr 24 22:57:54 EDT 2025
Tue Jul 01 05:07:30 EDT 2025
Thu Aug 29 12:04:35 EDT 2024
Thu Sep 05 18:04:37 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Ambulatory blood pressure
Salt-sensitive hypertension
Renal damage
PI3K-AKT signaling pathway
Growth factor
Language English
License This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
https://creativecommons.org/licenses/by-nc/4.0
2021 The Author(s). Published by S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c530t-99cc6467dbe1a9e3e0e4a15e6ea64ddca5c0ca8e0ca4f2764a753e023615e95a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/c934962130954573ac68b87b126aec2d
PMID 33794518
PQID 2543437518
PQPubID 33949
PageCount 9
ParticipantIDs proquest_journals_2543437518
karger_primary_515088
proquest_miscellaneous_2508591016
pubmed_primary_33794518
doaj_primary_oai_doaj_org_article_c934962130954573ac68b87b126aec2d
crossref_primary_10_1159_000515088
crossref_citationtrail_10_1159_000515088
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-04-01
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle Kidney & blood pressure research
PublicationTitleAlternate Kidney Blood Press Res
PublicationYear 2021
Publisher S. Karger AG
Karger Publishers
Publisher_xml – name: S. Karger AG
– name: Karger Publishers
References Kinsara AJ. Ambulatory blood pressure monitoring in daily practice. Indian Heart J. 2017 Nov–Dec;69(6):788–9.
Fehrenbach DJ, Mattson DL. Inflammatory macrophages in the kidney contribute to salt-sensitive hypertension. Am J Physiol Ren Physiol. 2020;318:544–8.
Toschi L, Jänne PA. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res. 2008;14(19):5941–6.
Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, . Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350(9093):1734–7.
Lu X, Crowley SD. Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 2018;20(12):103.
Mattson DL. Immune mechanisms of salt-sensitive hypertension and renal end-organ damage. Nat Rev Nephrol. 2019;15(5):290–300.
Sulyok E. [New aspects of the pathomechanism of salt-sensitive hypertension]. Orv Hetil. 2019;160(2):43–9.
Luft FC, Grim CE, Willis LR, Higgins JT, Weinberger MH. Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. Circulation. 1977;55(5):779–84.
Sutandy FX, Qian J, Chen CS, Zhu H. Overview of protein microarrays. Curr Protoc Protein Sci. 2013;Chapter 27:Unit 27.1.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
National Health and Family Planning Commission. Report on nutrition and chronic diseases of Chinese residents(2015).Version 1. Beijing: People's Health Publishing House; 2015. p. 48.
Chamarthi B, Williams JS, Williams GH. A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens. 2010;28(5):1020–6.
Thirone AC, Scarlett JA, Gasparetti AL, Araujo EP, Lima MH, Carvalho CR, . Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Diabetes. 2002;51(7):2270–81.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.
Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension. 1991;17(1 Suppl):I61–8.
Yamada M, Ichikawa Y, Yamagishi S, Momiyama N, Ota M, Fujii S, . Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer. Clin Cancer Res. 2008;14(8):2351–6.
Varma SS, Bhardwaj A, Pathak KA, Shrivastav A. Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell. Front Cell Dev Biol. 2020 May 5;8:286.
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–61.
Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. AM J MED. 1978;64(2):193–8.
Ren J, Crowley SD. Role of T-cell activation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol. 2019;316:1345–53.
ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – reference: Lu X, Crowley SD. Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 2018;20(12):103.
– reference: Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension. 1991;17(1 Suppl):I61–8.
– reference: Toschi L, Jänne PA. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res. 2008;14(19):5941–6.
– reference: Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.
– reference: Fehrenbach DJ, Mattson DL. Inflammatory macrophages in the kidney contribute to salt-sensitive hypertension. Am J Physiol Ren Physiol. 2020;318:544–8.
– reference: Ren J, Crowley SD. Role of T-cell activation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol. 2019;316:1345–53.
– reference: Yamada M, Ichikawa Y, Yamagishi S, Momiyama N, Ota M, Fujii S, . Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer. Clin Cancer Res. 2008;14(8):2351–6.
– reference: Thirone AC, Scarlett JA, Gasparetti AL, Araujo EP, Lima MH, Carvalho CR, . Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Diabetes. 2002;51(7):2270–81.
– reference: Kinsara AJ. Ambulatory blood pressure monitoring in daily practice. Indian Heart J. 2017 Nov–Dec;69(6):788–9.
– reference: Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
– reference: Mattson DL. Immune mechanisms of salt-sensitive hypertension and renal end-organ damage. Nat Rev Nephrol. 2019;15(5):290–300.
– reference: Sulyok E. [New aspects of the pathomechanism of salt-sensitive hypertension]. Orv Hetil. 2019;160(2):43–9.
– reference: National Health and Family Planning Commission. Report on nutrition and chronic diseases of Chinese residents(2015).Version 1. Beijing: People's Health Publishing House; 2015. p. 48.
– reference: Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–61.
– reference: Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. AM J MED. 1978;64(2):193–8.
– reference: Sutandy FX, Qian J, Chen CS, Zhu H. Overview of protein microarrays. Curr Protoc Protein Sci. 2013;Chapter 27:Unit 27.1.
– reference: Varma SS, Bhardwaj A, Pathak KA, Shrivastav A. Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell. Front Cell Dev Biol. 2020 May 5;8:286.
– reference: Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, . Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350(9093):1734–7.
– reference: Luft FC, Grim CE, Willis LR, Higgins JT, Weinberger MH. Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. Circulation. 1977;55(5):779–84.
– reference: Chamarthi B, Williams JS, Williams GH. A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens. 2010;28(5):1020–6.
– ident: ref6
  doi: 10.1038/s41581-019-0121-z
– ident: ref12
  doi: 10.1556/650.2019.31308
– ident: ref11
  doi: 10.1159/000180580
– ident: ref15
  doi: 10.1158/1078-0432.CCR-07-4499
– ident: ref3
  doi: 10.1016/0002-9343(78)90045-1
– ident: ref8
  doi: 10.1002/0471140864.ps2701s72
– ident: ref14
  doi: 10.1038/s41581-019-0121-z
– ident: ref17
  doi: 10.2337/diabetes.51.7.2270
– ident: ref2
  doi: 10.1161/01.cir.55.5.779
– ident: ref7
  doi: 10.1016/j.ihj.2017.09.223
– ident: ref5
  doi: 10.1016/S0140-6736(97)05189-1
– ident: ref10
  doi: 10.1093/eurheartj/eht151
– ident: ref4
  doi: 10.1097/HJH.0b013e3283375974
– ident: ref16
  doi: 10.1158/1078-0432.CCR-08-0071
– ident: ref9
  doi: 10.1093/nar/gkw1092
– ident: ref13
  doi: 10.1007/s11906-018-0903-x
– ident: ref1
  doi: 10.1161/01.hyp.17.1_suppl.i61
SSID ssj0005002
Score 2.2835858
Snippet Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains...
The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. We...
The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains...
SourceID doaj
proquest
pubmed
crossref
karger
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 236
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
ambulatory blood pressure
Blood pressure
Cell proliferation
Damage
Glomerular filtration rate
growth factor
Growth factors
Health care
Hospitals
Hypertension
Immune system
Insulin-like growth factor-binding protein 2
Insulin-like growth factor-binding protein 3
Insulin-like growth factor-binding protein 6
Lymphatic system
Medical research
Mortality
Neurotrophin 4
Pathogenesis
Patients
pi3k-akt signaling pathway
Platelet-derived growth factor
Population
Proteins
renal damage
Renal function
Research Article
Salt
salt-sensitive hypertension
Salts
Software
Statistical analysis
Traditional Chinese medicine
Vascular endothelial growth factor
Vascular endothelial growth factor receptors
Water circulation
SummonAdditionalLinks – databaseName: Karger Open Access
  dbid: M--
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwEB1BkapeELQFAgUZhBCXSNnEduJjF7FagRahlopeUOTYk6qiJFV2e-DfM2Nnw4foJQd7EkeesWfGfn4GeO0r6b1Ek6qssamsPA2pSrtUNV61qKXOkdchV5_08kx-OFfn43oHn4X5zvjnQI06cQuQww1XzzFzeXUX7lEeVTBL_ipNf4M5sogulJQMUcaiRw6hv17dg92iIPNTfMHHH04ocPWTA4pN3x5pBo-zeAD3x1BRHEfdPoQ72O3DwXFHafKPn-KNCODNsCq-D7urcY_8AL59pqCuv-A57HIt-lZEKIeYM0RdxOOAAwrbefG1H9YoTpCbWZCDYyWJy06c2qtNesrQdp4MxZJy1SEg3fvuEM4W77-8W6bjJQqpU0W2SY1xjrq89A3OrMECM5R2plCj1aQmZ5XLnK2QHrLNSy0tJTDIvPIkZJQtHsFO13f4BIQtTauKcuaog6X0lW18ZnNsTakaiguzBN5ue7V2I8M4X3RxVYdMQ5l60kUCrybR60ir8T-hOatmEmAm7FDQDxf1OLBqZ5jyPidXbCgYLAvrdNVUZTPLtUWX-wQOo2Knz2w_fvRP-cf5Sayqr31L1VszqMdRva7zcA6XN6oSeDlV03jkTRbbYX_DMkwZx2siCTyO5jO1sDW_p7f80zPYyxkyE4BBR7CzGW7wOcU8m-ZFMPdf8in2zQ
  priority: 102
  providerName: Karger AG
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLgrbQQKkMQohLRDbxIz6hbtXVClSEWir2giLHnlQVJVmy2wP_nhnHmwpUuOwhnnUkjz0vf_mGsde-FN4LMKnMapuK0uORKpVLZe1lA0qoHKgOefJJzc_Fh4VcxILbKsIqNzYxGGrfOaqRv8vDN5B0SfB--TOlrlF0uxpbaNxl94i6jCBdeqFvIB7ZgDkUmCJhHqMisxB68NDLjqjQyz_8UaDtR1_0nVDY_b-DzuB8Zo_Ywxg18sNBzY_ZHWi32c5hixnzj1_8DQ84zlAg32b3T-J1-Q779hnju-6CzNnlincNH1AdfEpodT58GdgDt63nX7t-BfwU6DUz9HWkL37Z8jN7tU7PCOVOdpHPMW3tA-i9a3fZ-ez4y9E8jf0UUieLbJ0a4xyuvvY1TKyBAjIQdiJBgVWoMWely5wtAX9Ek2slLOYyQBTzKGSkLZ6wrbZrYY9xq00jCz1xuKpC-NLWPrM5NEbLGkPELGFvN6tauUg2Tj0vrqqQdEhTjQpI2KtRdDkwbNwmNCXVjAJEih0edP1FFc9Y5Qyx3-folQ3GhbqwTpV1qetJriy43Cdsd1DsOM1m8v2_nn-cng5D1dI3OLzZBlU84KvqZjsm7OU4jEeT7ltsC901yRB7HJVHEvZ02D7jG4oCDSH--9n_J3_OHuQEoglQoX22te6v4QVGQev6IGz134LsAlA
  priority: 102
  providerName: ProQuest
Title Pathogenesis of Higher Blood Pressure and Worse Renal Function in Salt-Sensitive Hypertension
URI https://karger.com/doi/10.1159/000515088
https://www.ncbi.nlm.nih.gov/pubmed/33794518
https://www.proquest.com/docview/2543437518
https://www.proquest.com/docview/2508591016
https://doaj.org/article/c934962130954573ac68b87b126aec2d
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgLog8gUFYGIcQlIpvYTnzsoq5WoK2qLRV7QZFjT1DVNqmy2wP_nhk7iaACceGSQzx5ecbzsL98ZuytK4RzAnQsk8rEonA4pAplY1k5WYMSKgWah1yeqMW5-LSW61-2-iJMWKAHDh33wWqiNE_R1WoM9nlmrCqqIq-mqTJgU0feF2PeUEwN4I4koA0FFkdYwaieUwhjt9_FjkjQi98ikSfsxyh0Sfjr7u_ppg878yfscZ8v8qPwnrvsHjR7bP-owVr5-gd_xz2C00-N77GHy36hfJ99O8XMrv1Ojuxiw9uaBzwHnxFOnYd_AjvgpnH8a9ttgK-AHjPHKEea4hcNPzNX2_iM8O3kEfkCC9bOw93b5oCdz4-_fFzE_U4KsZVZso21thb7PXcVTI2GDBIQZipBgVGoK2ukTawpAA-iTnMlDFYxQOTyKKSlyZ6ynaZt4DnjJte1zPKpxV4VwhWmcolJoda5rDA5TCL2fujV0vY047TbxVXpyw2py1EBEXszit4Ebo0_Cc1INaMA0WH7E2gkZW8k5b-MJGIHQbHjbYabH945_3m2Ck3ljauxeTCDsh_amzL1P-PSalXEXo_NOChppcU00N6SDPHG0cRIxJ4F8xmfkGXoAvHqF__jw16yRymBbDyU6JDtbLtbeIVZ0raasPv5Op-wB7Pjk9PVxA8PPC7j-CerQQ0W
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQS9IGgLDRQwCBCXiGxi53FAqAtdbdnuqtq2ai8oOLZTVZRkyW6F-qf4jcw4jwoE3HrJIZ44lj0ef2N_ngF4qWOuNTeJK7xMujzWOKXiULki0yI3IQ99Q_uQk2k4OuafTsXpCvxs78IQrbK1idZQ61LRHvlb396BpEOC9_PvLmWNotPVNoVGrRZjc_UDXbbFu72POL6vfH-4e_Rh5DZZBVwlAm_pJolS2IZIZ6YvExMYz3DZFyY0MsR2KymUp2Rs8MFzPwq5RERvKNA6CiVCBljvLVjlAboyPVgd7E4PZtekEq9mOXJ0ytBzCptYRogZbPY8Cr4e_7YC2kQBuPp9Jd539W-Ya5e74T242-BUtlMr1n1YMcU6bOwU6KN_u2KvmWWO2i35dbg9aQ7oN-DzASLK8owM6PmClTmreSRsQPx4Vt9FrAyThWYnZbUwbGboN0NcXUlD2HnBDuXF0j0kXj1ZYjZCR7myNPuy2ITjG-nrB9ArysJsAZNRkosg6ivsVc51LDPtSd_kSSQyBKWeA2_aXk1VE96csmxcpNbNEUnaDYADLzrReR3T429CAxqaToDCcNsXZXWWNrM6VQnF2_cRBySIRKNAqjDO4ijr-6E0ytcObNYD21XTVr79x_vxYFYXpXOdY3GrBmljUhbp9QRw4HlXjMaATnhkYcpLkqF4dbQh48DDWn26PwQBml78-tH_K38Gd0ZHk_10f286fgxrPlF4LFFpG3rL6tI8QQy2zJ42is_gy03PtV-WzEG9
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcELQFFgoYBIhL1Gxi53FAqEtZtSytqpaKvVTBsSdVRUmW7Faof41fx4zzqEDArZc9xLPOrj0z_sb-PAPwwibSWompp_xcezKxZFJJZDyVW1VgJKMAeR9ybz_aOZYfpmq6BD-7uzBMq-x8onPUtjK8R74ZuDuQfEiwWbS0iIPt8dvZd48rSPFJa1dOo1GRCV7-oPBt_mZ3m-b6ZRCM3396t-O1FQY8o0J_4aWpMfR7YpvjUKcYoo9SDxVGqCP6D0Yr4xudIH3IIogjqQndIyddJ6FU6ZD6vQE341AN2cbiaXxFL_EbvqOk8IxiqKjNakTowdXR4zTsyW9roSsZQOvgV2aA1_8GvG7hG9-B2y1iFVuNit2FJSxXYW2rpGj926V4JRyH1G3Or8LKXntUvwYnB4Qtq1N2pWdzURWiYZSIETPlRXMrsUahSys-V_UcxSHya8a0zrKuiLNSHOnzhXfEDHv2yWKHQubaEe6rch2Or2Wk78FyWZX4AISO00KF8dDQqEppE51bXwdYpLHKCZ76A3jdjWpm2kTnXG_jPHMBj0qzfgIG8LwXnTXZPf4mNOKp6QU4Ibd7UNWnWWvfmUk5835AiCAlTBqH2kRJnsT5MIg0msAOYL2Z2L6brvONP55PRodNUzazBTV3apC1zmWeXZnCAJ71zeQW-KxHl1hdsAxnruOtmQHcb9Snf0MYkhOmbz_8f-dPYYUsLPu4uz95BLcC5vI4xtIGLC_qC3xMYGyRP3FaL-DLdZvZLyMNRI0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pathogenesis+of+Higher+Blood+Pressure+and+Worse+Renal+Function+in+Salt-Sensitive+Hypertension&rft.jtitle=Kidney+%26+blood+pressure+research&rft.au=Yuguang+Chu&rft.au=Yan+Zhou&rft.au=Shihua+Lu&rft.au=Feng+Lu&rft.date=2021-04-01&rft.pub=Karger+Publishers&rft.issn=1420-4096&rft.eissn=1423-0143&rft.volume=46&rft.issue=2&rft.spage=236&rft.epage=244&rft_id=info:doi/10.1159%2F000515088&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c934962130954573ac68b87b126aec2d
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-4096&client=summon